Skip to content

C83.52 ICD-10-CM Code: Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes

C83.52 maps to CMS-HCC V28 20. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupC83.52

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

C83.52

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes

A type of blood cancer affecting immature lymphoid cells located in the lymph nodes within the chest cavity.

Buddy the Bee presenting code insight

Buddy Insight

Lymphoblastic lymphoma of intrathoracic lymph nodes is particularly important because T-cell lymphoblastic lymphoma frequently presents as a mediastinal (thymic) mass in adolescents and young adults.

CMS-HCC V28

HCC 20

Coefficient HCC 20: 1.136 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 010

Code-level coefficient reference

ESRD/PACE

HCC 10

Code-level coefficient reference

RXHCC

HCC 21

Code-level coefficient reference

Inclusion Terms

Official
  • B-precursor lymphomaInherited from C83.5
  • Lymphoblastic B-cell lymphomaInherited from C83.5
  • Lymphoblastic lymphoma NOSInherited from C83.5
  • Lymphoblastic T-cell lymphomaInherited from C83.5
  • T-precursor lymphomaInherited from C83.5

Excludes 2

Official
  • Kaposi's sarcoma of lymph nodes (C46.3)Inherited from C81-C96
  • secondary and unspecified neoplasm of lymph nodes (C77.-)Inherited from C81-C96
  • secondary neoplasm of bone marrow (C79.52)Inherited from C81-C96
  • secondary neoplasm of spleen (C78.89)Inherited from C81-C96

Includes

Official

No Includes notes are included in this display for C83.52. Check the code and parent instructions in the Code Book.

Excludes 1

Official
  • personal history of non-Hodgkin lymphoma (Z85.72)Inherited from C83

Code First

Official

No Code First sequencing instructions are included in this display for C83.52. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for C83.52. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for C83.52. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Pathology confirmation with TdT and T-cell or B-cell lineage markers
CT chest documenting mediastinal mass or intrathoracic lymphadenopathy
Assessment for airway compromise or superior vena cava syndrome
Bone marrow biopsy to distinguish from leukemia

MEAT Support

HCC Buddy guidance
Pathology confirmation with TdT and T-cell or B-cell lineage markers
CT chest documenting mediastinal mass or intrathoracic lymphadenopathy
Assessment for airway compromise or superior vena cava syndrome
Bone marrow biopsy to distinguish from leukemia

Audit Caution

HCC Buddy guidance
Confusing mediastinal lymphoblastic lymphoma with primary mediastinal large B-cell lymphoma (different entity)
Not urgently evaluating for airway compromise in anterior mediastinal mass
Failing to perform bone marrow biopsy to distinguish lymphoma from leukemia
Coding pleural effusion involvement separately without recognizing it as part of the thoracic disease

Common Mistakes

HCC Buddy guidance
C85.22 — Mediastinal large B-cell lymphoma, intrathoracic; mature B-cell lymphoma vs. immature precursor
C83.32 — DLBCL, intrathoracic; mature large B-cell vs. immature lymphoblastic
C83.72 — Burkitt lymphoma, intrathoracic; different biology despite both being aggressive
C91.00 — Acute lymphoblastic leukemia; bone marrow blasts >25% indicates leukemia

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is C83.52 an HCC code?

Yes. C83.52 (Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes) maps to HCC 20, Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 1.136. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: C83.52 is billable and maps to V28 HCC 20, Lung and Other Severe Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
C83.52
Description
Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes
HCC (V28)
HCC 20 — Lung and Other Severe Cancers
RAF reference coefficient
1.136
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 20, Lung and Other Severe Cancers
1.136
ESRDHCC 10, Lymphoma and Other Cancers
Not separately weighted
RxHCCHCC 21, Lymphomas and Other Hematologic Cancers
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work C83.52 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for C83.52

For C83.52, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

C83.52 is the ICD-10-CM diagnosis code for lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes. A type of blood cancer affecting immature lymphoid cells located in the lymph nodes within the chest cavity. C83.52 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).

Under the CMS-HCC V28 risk adjustment model, C83.52 maps to Lung and Other Severe Cancers (HCC 20) with a source-labeled community, non-dual, aged reference coefficient of 1.136. No V24 mapping is shown for C83.52; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Confirm documentation indicates intrathoracic (within the chest) lymph node involvement. For C83.52, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C83.52 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Confirm documentation indicates intrathoracic (within the chest) lymph node involvement
  • This includes mediastinal and other thoracic lymph nodes; do not use for lung parenchymal involvement

Clinical Significance

Lymphoblastic lymphoma of intrathoracic lymph nodes is particularly important because T-cell lymphoblastic lymphoma frequently presents as a mediastinal (thymic) mass in adolescents and young adults. This presentation can cause airway compromise, superior vena cava syndrome, and pleural effusions, requiring urgent evaluation and sometimes emergency treatment initiation.

Documentation Requirements

  • Pathology confirmation with TdT and T-cell or B-cell lineage markers
  • CT chest documenting mediastinal mass or intrathoracic lymphadenopathy
  • Assessment for airway compromise or superior vena cava syndrome
  • Bone marrow biopsy to distinguish from leukemia
  • CNS evaluation and pleural fluid analysis if effusion present

Commonly Confused Codes

  • C85.22: Mediastinal large B-cell lymphoma, intrathoracic; mature B-cell lymphoma vs. immature precursor
  • C83.32: DLBCL, intrathoracic; mature large B-cell vs. immature lymphoblastic
  • C83.72: Burkitt lymphoma, intrathoracic; different biology despite both being aggressive
  • C91.00: Acute lymphoblastic leukemia; bone marrow blasts >25% indicates leukemia

Child Codes

Code Hierarchy

Also searched as

  • C83 52
  • C8352

For C83.52, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

C83.52 maps to CMS-HCC V28 category 20, Lung and Other Severe Cancers. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for C83.52. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work C83.52 in HCC Buddy

Open C83.52 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.